Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up
HAIKOU, China, Jan. 5, 2026 /PRNewswire/ -- A news report from Haikou Municipal Bureau of Tourism, Culture, Radio, Television and Sports: As a key hub of the Hainan Free Trade Port, Haikou is advancing its opening-up and global engagement through...
CCTV+: Xi Outlines Main Directions for Developing New Quality Productive Forces
BEIJING, Jan. 3, 2026 /PRNewswire/ -- Chinese President Xi Jinping has conducted in-depth fieldwork and inspections at the production frontline over the past year, outlining the breakthroughs and main directions for developing new quality productive...
Foreign Executive Witnesses Rise of Intelligent Manufacturing in east China's Jiangxi
YICHUN, China, Dec. 30, 2025 /PRNewswire/ -- A report from Jiangxi International Communication Center (JXICC): Since the beginning of the 14th Five-Year Plan, east of China's Jiangxi Province has firmly grasped the key task of achieving new-type...
RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA
HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Against the backdrop of real-world asset (RWA) digitization gradually moving from concept to practical application worldwide, Southeast Asia is emerging as a key frontier for the next wave of innovation and...
SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model
SKT consortium conducts Korean government's 'Sovereign AI Foundation Model' project with A.X K1, positioning Korea for Global Top 3 AI Powers A.X K1: Korea's first 'Teacher Model' for smaller and specialized applications SK Telecom realizes AI as...
Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined...
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology...
T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II...
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university BELLEVUE, Wash., Dec. 20, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH)...
Robo.ai Inc. Submits Application to Participate in the Pre-Restructuring Strategic Investor Selection of Shanghai JIDU Automobile Co., Ltd.
DUBAI, UAE, Dec. 19, 2025 /PRNewswire/ -- On December 19, 2025, Robo.ai Inc. (NASDAQ: AIIO) officially submitted its application to the provisional administrator of Shanghai JIDU Automobile Co., Ltd. (JIDU Auto), seeking to participate in its...